Feedback / Questions
volagidemab (REMD-477) - Amgen, REMD Bio
http://clinicaltrials.gov/ct2/show/NCT07212868
Oct 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next